加拿大皇家银行将阿普提夫的目标价格从86.00美元降低到85.00美元,而其他分析家也调整了目标。 Royal Bank of Canada lowered Aptiv's target price from $86.00 to $85.00, while other analysts also adjusted their targets.
加拿大皇家银行将其Aptiv的目标价格从86.00美元降至85.00美元,保持了优异的评级。 Royal Bank of Canada reduced its target price for Aptiv from $86.00 to $85.00, maintaining an outperform rating. 普蒂夫报告的Q2 EPS为1.58美元,比协商一致估计的1.42美元超出0.16美元。 Aptiv reported Q2 EPS of $1.58, surpassing the consensus estimate of $1.42 by $0.16. 其他分析家也进行了价格调整,包括高盛集团将其目标从118美元降至101.0美元,花旗集团将其价格目标从128美元降至108美元。 Other analysts also made price adjustments, including Goldman Sachs Group lowering its target from $118.00 to $101.00, and Citigroup cutting its price objective from $128.00 to $108.00. Aptiv的Q2收入为50.5亿美元,低于分析师估计的53亿美元。 Aptiv's revenue for Q2 was $5.05 billion, lower than analyst estimates of $5.30 billion.